Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hypertension × Sunitinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Renal Cell 117 Kidney Neoplasms 36 Neoplasms 31 Breast Neoplasms 28 Neoplasm Metastasis 27 Gastrointestinal Stromal Tumors 27 Carcinoma, Non-Small-Cell Lung 21 Prostatic Neoplasms 14 Urinary Bladder Neoplasms 11 Glioblastoma 11 Colorectal Neoplasms 11 Pancreatic Neoplasms 9 Lung Neoplasms 9 Carcinoma 9 Brain Neoplasms 9 Melanoma 8 Carcinoma, Hepatocellular 8 Stomach Neoplasms 7 Sarcoma 7 Neuroendocrine Tumors 7 Adenoma, Islet Cell 7 Thyroid Neoplasms 6 Small Cell Lung Carcinoma 6 Ovarian Neoplasms 6 Liver Neoplasms 6 Clear-cell metastatic renal cell carcinoma 6 Uveal Melanoma 5 Thymoma 5 Solid Tumors 5 Multiple Myeloma 5

Interventions

relacorilant 5 Hydrochlorothiazide 4 Nutrition Assessment 3 Bevacizumab 3 Amlodipine 3 aliskiren 2 Osilodrostat 2 Lisinopril 2 Labetalol 2 Angiotensin-Converting Enzyme Inhibitors 2 ziprasidone 1 sacubitril and valsartan sodium hydrate drug combination 1 pembrolizumab 1 pazopanib 1 lutetium Lu 177 dotatate 1 gallium Ga 68 dotatate 1 fimasartan 1 enzalutamide 1 clevidipine 1 bicalutamide 1 benazepril 1 Zolpidem 1 Warfarin 1 Vitamin D 1 Vecuronium Bromide 1 Vancomycin 1 Urine Specimen Collection 1 Tranexamic Acid 1 Tobramycin 1 Thiazides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04368546 2021-01-27

Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)

Charite University, Berlin, Germany

Hypertension

Data powered by HemOnc (CC BY 4.0) Colophon ⚡